Stay updated with breaking news from Sustained Limus Release. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cordis, a developer and manufacturer of interventional cardiovascular and endovascular technologies, has recently acquired Swiss medical technology
Get latest articles and stories on Business at LatestLY. Geneva [Switzerland], October 2: Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of USD 35M and a 2023 upfront closing payment of USD 200M, together with regulatory achievement milestones of up to USD 125M and commercial milestones of up to USD 775M through 2029, for a total consideration of up to USD 1.135 Billion. Business News | MedAlliance Acquired by Cordis for Up to USD 1.135 Billion.
GENEVA, Switzerland, Oct. 2, 2023 /PRNewswire/ -- Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of
/PRNewswire/ -- Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, today announced...
MIAMI LAKES, Fla., Oct. 3, 2023 /PRNewswire/ -- Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular a...